Reply to: "Understanding the Contribution of Anti-EGFR Reinduction to Overall Survival in TRIPLETE Study" and

Veronica Conca1, Daniele Rossini1, Chiara Cremolini1

  • 1Conca Veronica, MD, PhD, Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy, Rossini Daniele, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, Cremolini Chiara, MD, PhD, Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.

Abstract

No abstract available in PubMed .